Neutrophil-Mediated Delivery Platforms for Synergistic Chemo-Immunotherapy of Non-Small-Cell Lung Cancer Therapy
Nano Letters · 2025
DOI: 10.1021/acs.nanolett.5c04210 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2025. Verfasst von Rongze Sun und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neutrophils, Paclitaxel. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jilin Province, Department of Science and Technology of Jilin Province.
Abstract (Originalsprache)
Traditional nanocarriers possess good therapeutic efficacy in the treatment of non-small-cell lung cancer (NSCLC), but usually suffer from high immunogenicity, poor biosafety, and low targeting. In this work, a neutrophil-mediated delivery platform constructed from neutrophils (NEs) and paclitaxel/transforming growth factor-β (TGF-β) siRNA loaded cationic liposome, namely, siTGFβ-PLP-NEs, is fabricated for the combination therapy of NSCLC via synergistic chemo-immunotherapy. siTGFβ-PLP-NEs can be targeted to the tumor site and effectively release paclitaxel and siTGFβ, which is conducive to simultaneously inhibiting the proliferation of tumor cells and the expression of TGF-β. The experimental results demonstrate that siTGFβ-PLP-NEs can prevent the transition of tumor-associated NEs from an anti-tumor (N1) phenotype to a pro-tumor (N2) phenotype, enhance CD8+ T cell infiltration, and reduce regulatory T cell (Treg) infiltration, which provides a great promising combination therapy option to use neutrophil-mediated systems as a general-purpose delivery platform for the treatment of NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, Jilin University, 2699 Qianjin Street, Changchun 130012, P. R. China.
ORCID-Profile: Jie Yang, Lesheng Teng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jilin Province
- Department of Science and Technology of Jilin Province
- Ministry of Science and Technology of the People's Republic of China
Zitieren
APA
Sun, R., Jiao, Y., Chen, J., Pang, X., Xue, B., Yao, J., Li, G., Zhang, Y., Yang, J., & Teng, L. (2025). Neutrophil-Mediated Delivery Platforms for Synergistic Chemo-Immunotherapy of Non-Small-Cell Lung Cancer Therapy. Nano Letters. https://doi.org/10.1021/acs.nanolett.5c04210
Vancouver
Sun R, Jiao Y, Chen J, Pang X, Xue B, Yao J, et al. Neutrophil-Mediated Delivery Platforms for Synergistic Chemo-Immunotherapy of Non-Small-Cell Lung Cancer Therapy. Nano Letters. 2025. doi:10.1021/acs.nanolett.5c04210
BibTeX
@article{Sun2025,
author = {Sun, Rongze and Jiao, Yunshuang and Chen, Jicong and Pang, Xiang and Xue, Beilin and Yao, Jiaqi and Li, Guanpeng and Zhang, Yue and Yang, Jie and Teng, Lesheng},
title = {Neutrophil-Mediated Delivery Platforms for Synergistic Chemo-Immunotherapy of Non-Small-Cell Lung Cancer Therapy},
journal = {Nano Letters},
year = {2025},
doi = {10.1021/acs.nanolett.5c04210}
}
EUVIMED